Cushing's Syndrome

Synonym: hypercortisolism

Cushing syndrome is caused by prolonged exposure to elevated levels of either endogenous or exogenous glucocorticoids. The degree of cortisol overproduction is very variable. When presentation is florid, diagnosis is usually straightforward.¹ But the presentation may be subtle and the combination of non-specific clinical manifestations and variable cyclical biochemical parameters often makes the diagnosis difficult.²

• Incidence ranges from 0.7 to 2.4 per million population per year. However new data suggest that Cushing's syndrome is more common than previously thought.
• In obese patients with type 2 diabetes, especially those with poor blood glucose control and hypertension, the reported prevalence of Cushing's syndrome is between 2% and 5%.

Risk factors

• Cushing's syndrome due to an adrenal or pituitary tumour is more common in females (ratio 5:1).
• The peak incidence of Cushing syndrome caused by an adrenal or pituitary adenoma is between the ages of 25 and 40 years.
• Ectopic ACTH production due to lung cancer occurs later in life.

Most common cause of Cushing's syndrome is the use of exogenous glucocorticoids. Endogenous Cushing's syndrome is divided into corticotropin-dependent and corticotropin-independent causes:

• Corticotropin-dependent causes account for about 80-85% of cases:
  • 80% are due to pituitary adenomas (Cushing's disease).
  • The remaining 20% are due to ectopic corticotropin syndrome, which is usually due to small-cell carcinoma of the lung and bronchial carcinoid tumours, but may occur with almost any endocrine tumour, e.g. phaeochromocytoma, pancreatic neuroendocrine tumours, medullary thyroid cancer, gut carcinoids.
• Corticotropin-independent Cushing's syndrome:
  • Is most often due to a unilateral tumour: adrenal adenoma in 60% and adrenal carcinoma in 40% of cases.
  • Very rare adrenal causes of Cushing's syndrome are corticotropin-dependent macronodular adrenal hyperplasia, primary pigmented nodular adrenal disease and McCune-Albright syndrome.

• Truncal obesity, supraclavicular fat pads, buffalo hump, weight gain
• Facial fullness, moon facies
• Proximal muscle wasting and weakness
• Diabetes or glucose intolerance
• Gonadal dysfunction
• Hypertension
• Skin: skin atrophy, purple striae, easy bruising, hirsutism, acne
• Psychological problems: depression, cognitive dysfunction, and emotional lability
• Osteopenia or osteoporosis
• Oedema
• Women may complain of irregular menses
• Thirst, polydipsia, polyuria
• Impaired immune function: increased infections, difficulty with wound healing
• Child: growth retardation
• Patients with an ACTH-producing pituitary tumour may develop headaches, visual problems, and galactorrhoea
• Destruction of the anterior pituitary may cause hypothyroidism and amenorrhoea

Pseudo-Cushing's syndrome: all or some of the clinical features of Cushing's syndrome, combined with biochemical evidence of hypercortisolism. Causes include:

• Chronic severe anxiety and/or depression
• Chronic alcoholism/alcohol withdrawal syndrome
• Obesity
• Poorly controlled diabetes
• HIV infection

No single test is perfect and several different tests are usually needed. Investigation should be done when there is no acute concurrent illness (e.g. infection or heart failure) as these can cause false-positive results. The 3 main tests for diagnosis of Cushing's syndrome are: 24-h urinary free cortisol, low-dose dexamethasone suppression test, and assessment of midnight plasma cortisol or late-night salivary cortisol.

• Full blood count: raised white cell count.
• Electrolytes and acid-base balance: hypokalemia, metabolic alkalosis.
• 24 hour urinary free cortisol
  • Ideally three collections. Measure creatinine excretion at the same time.
  • Cushing's syndrome can be confidently diagnosed if two or more collections measure cortisol excretion as more than three time the laboratory upper limit of normal.
  • Need to repeat the test if creatinine excretion varies by more than 10% between collections.
  • False positives may occur with pregnancy, anorexia, exercise, psychoses, alcohol and alcohol withdrawal. Strenuous exercise and illness raise cortisol secretion.
• Low dose dexamethasone suppression test
  • Useful screening test in those who are unable to reliably collect a 24 hour urine sample.
  • 1 mg of dexamethasone is ingested at 11 pm, and serum cortisol is measured at 8 am the next morning.
  • Mild Cushing syndrome is often difficult to distinguish from normal cortisol secretion or pseudo-Cushing, and both false-positive and false-negative test results occur.
• Midnight cortisol levels
  • Taken between 11 pm and 1 am. Demonstrate loss of normal diurnal variation of reduced cortisol production in the evening compared to the morning.
  • Need to take blood from indwelling cannula with patient in a relaxed state.
  • Inconvenient but reliable test for Cushing's syndrome.
  • Late-night salivary cortisol measurement is a simple and reliable screening test for Cushing's syndrome.³
• Dexamethasone suppressed CRH test
  • Modification of the low dose dexamethasone suppression test.
  • Intravenous CRH is given 2 hours after 48 hours (eight doses) of 0.5 mg dexamethasone. Serum cortisol is measured 15 minutes after ovine CRH administration.
  • Very reliable test for Cushing's syndrome.

Investigations to identify the cause of Cushing's syndrome

• Plasma ACTH
  • Secretion is intermittent.
  • Two measurements showing suppressed ACTH with high cortisol suggests a pituitary adenoma. This should then be followed by abdominal CT or MRI scan.
  • If the plasma ACTH level is detectable then the following tests are indicated:
• High dose dexamethasone suppression test
  • The 8 mg overnight dexamethasone suppression test and the 48-hour high-dose dexamethasone test may be useful when baseline ACTH levels are equivocal. They also help in determining whether a patient has pituitary or ectopic ACTH production.
  • Greater than 90% reduction in basal urinary free cortisol levels supports the diagnosis of a pituitary adenoma; ectopic ACTH causes lesser degrees of suppression.
• Inferior petrosal sinus sampling (IPS):
  • Performed with CRH stimulation to aid in determining the source of excess ACTH.
  • A baseline and stimulated ratio of IPS to peripheral ACTH of less than 1.8 is suggestive of ectopic ACTH, while a ratio of IPS to peripheral ACTH of greater than 2 is consistent with a pituitary adenoma.
• MRI of the pituitary
• Chest and abdominal CT scans: for patients with suspected adrenal tumours or ectopic ACTH.
• Plasma CRH: ectopic CRH production is a very rare cause of Cushing's syndrome.

The treatment of choice in most patients is surgical,⁴ but the metabolic consequences, including increased tissue fragility, poor wound healing, hypertension, and diabetes mellitus, increase the risks of surgery.⁵

Drugs¹

• Metyrapone, ketoconazole, and mitotane can all be used to lower cortisol by directly inhibiting synthesis and secretion in the adrenal gland.
• Metyrapone and ketoconazole are enzyme inhibitors and have rapid onset of action, but control of hypercortisolism is often lost with corticotropin oversecretion in Cushing's disease. These drugs are not usually effective as long-term treatment and are used mainly for preparation for surgery or as adjunctive treatment after surgery or pituitary radiotherapy.
• Mitotane acts as an adrenolytic drug with delayed onset but long-lasting action, but control of corticotropin oversecretion in Cushing's disease is maintained.
• Medical treatment can also be used in patients who are unwilling or unfit for surgery. Treatment can be used long term for patients with ectopic corticotropin secretion, but adrenalectomy may be preferred.
• Etomidate can be used for acute control of severe hypercortisolaemia.

Surgical treatment

Is the treatment of choice with the following conditions:

• Pituitary tumours: trans-sphenoidal microsurgery.⁶ Radiation therapy may be used as an adjunct for patients who are not cured.⁷ Bilateral adrenalectomy may be necessary to control toxic cortisol levels.
• Adrenocortical tumours: require surgical removal. Laparoscopic surgery is now the treatment of choice for unilateral adrenal adenomas.¹
• Removal of neoplastic tissue is indicated for ectopic ACTH production. Metastatic spread makes a surgical cure unlikely or impossible. Bilateral adrenalectomy is indicated if necessary to control toxic cortisol levels.

Pituitary radiotherapy

• Persisting hypercortisolaemia after trans-sphenoidal surgery can be treated with pituitary radiotherapy.
• Conventional fractionated radiotherapy is very effective but is associated with long-term hypopituitarism and can be very delayed in effectiveness.

Patients with Cushing's syndrome often develop:

• Metabolic syndrome
• Hypertension
• Impaired glucose tolerance and diabetes
• Obesity
• Hyperlipidaemia: raised LDL cholesterol and triglycerides
• Coagulopathy: thrombophilia
• Osteoporosis
• Perforated viscera
• Impaired immunity, including opportunistic fungal infections
• Nelson's syndrome: may follow bilateral adrenalectomy for Cushing's disease
• A primary pituitary tumour may cause pan-hypopituitarism and visual loss

Patients with incompletely controlled Cushing's syndrome have a five-fold excess mortality.¹
• The usual course is chronic, with cyclic exacerbations and rare remissions.
• The prognosis is guardedly favorable with surgery.
• The rare adrenocortical carcinomas have a 5-year survival rate of 30% or less.